Full text
PDFPage 470
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Crawford C. L. Use of thalidomide in leprosy. BMJ. 1991 Jun 29;302(6792):1603–1604. doi: 10.1136/bmj.302.6792.1603-d. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fullerton P. M., O'Sullivan D. J. Thalidomide neuropathy: a clinical electrophysiological, and histological follow-up study. J Neurol Neurosurg Psychiatry. 1968 Dec;31(6):543–551. doi: 10.1136/jnnp.31.6.543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gad S. M., Shannon E. J., Krotoski W. A., Hastings R. C. Thalidomide induces imbalances in T-lymphocyte sub-populations in the circulating blood of healthy males. Lepr Rev. 1985 Mar;56(1):35–39. doi: 10.5935/0305-7518.19850006. [DOI] [PubMed] [Google Scholar]
- Karat A. B., Karat S., Job C. K., Sudarsanam D. Acute necrotizing lepromatous lymphadenitis: an erythema-nodosum-leprosum-like reaction in lymph nodes. Br Med J. 1968 Oct 26;4(5625):223–224. doi: 10.1136/bmj.4.5625.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Runne U., Orfanos C. E. Cutaneous neural proliferation in highly pruritic lesions of chronic prurigo. Arch Dermatol. 1977 Jun;113(6):787–791. [PubMed] [Google Scholar]
- Sampaio E. P., Sarno E. N., Galilly R., Cohn Z. A., Kaplan G. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med. 1991 Mar 1;173(3):699–703. doi: 10.1084/jem.173.3.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WATERS M. F., RIDLEY D. S. NECROTIZING REACTIONS IN LEPROMATOUS LEPROSY. A CLINICAL AND HISTOLOGIC STUDY. Int J Lepr. 1963 Oct-Dec;31:418–436. [PubMed] [Google Scholar]
- Wulff C. H., Høyer H., Asboe-Hansen G., Brodthagen H. Development of polyneuropathy during thalidomide therapy. Br J Dermatol. 1985 Apr;112(4):475–480. doi: 10.1111/j.1365-2133.1985.tb02323.x. [DOI] [PubMed] [Google Scholar]